Asset Purchase Agreement - Summary of Activity for the Bridge Purchase Agreement (Details) - Bridge Medicines - USD ($) $ in Thousands	Dec. 31, 2024	Oct. 07, 2024
Business Acquisition [Line Items]
Fair value of common stock	$ 530
Fair value of preferred stock	1,360
Transaction costs	2,505
Total costs	$ 4,395	$ 4,400

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-5

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration